Patents by Inventor William M. Shih

William M. Shih has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11767523
    Abstract: Provided herein, in some embodiments, are methods, compositions and kits for large-scale production of long single-stranded DNA in solution.
    Type: Grant
    Filed: September 11, 2017
    Date of Patent: September 26, 2023
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: Elisha Krieg, William M. Shih
  • Publication number: 20230146476
    Abstract: Provided herein are compositions and methods for determining the structure of individual targets by determining long-range distances within such targets.
    Type: Application
    Filed: February 26, 2021
    Publication date: May 11, 2023
    Applicants: President and Fellows of Harvard College, Children's Medical Center Corporation, Dana-Farber Cancer Institute, Inc.
    Inventors: James I. MacDonald, Michael H. Raez, William M. Shih, Wesley Philip Wong
  • Publication number: 20220403453
    Abstract: Provided herein, in some embodiments, are methods, compositions and kits for controlling nucleation and assembly of molecular nanostructures, microstructures and macrostructures.
    Type: Application
    Filed: January 14, 2022
    Publication date: December 22, 2022
    Applicants: President and Fellows of Harvard College, Dana-Farber Cancer Institute, Inc.
    Inventors: Dionis Minev, Christopher Wintersinger, William M. Shih
  • Publication number: 20220305119
    Abstract: Provided herein, in some embodiments, are nucleic acid nanostructure-based vaccines.
    Type: Application
    Filed: June 5, 2020
    Publication date: September 29, 2022
    Applicants: Dana-Farber Cancer Institute, Inc., Korea Institute of Science and Technology
    Inventors: William M. Shih, Ju Hee Ryu, Yang Zeng
  • Patent number: 11414694
    Abstract: The present disclosure provides nucleic acid-based nanoswitch catenanes and methods of use. A nanoswitch catenane may include a single-stranded nucleic acid comprising a first and second terminal domain linked to each other to form a host ring by one of a first, second or third switchable bridges, wherein the first switchable bridge is formed in the presence of a reaction agent through the reaction of two cognate functional groups, each linked to a terminal domain of the single-stranded nucleic acid, wherein the second switchable bridge is formed in the presence of a biomolecule of interest through binding of the bio-molecule of interest to two cognate antibodies, each linked to a terminal domain of the single stranded nucleic acid, and wherein the third switchable bridge is a link between two cognate functional groups that breaks in the presence of a dissociation agent. A nanoswitch catenane may also include a circular nucleic acid guest ring catenated with the host ring.
    Type: Grant
    Filed: March 9, 2017
    Date of Patent: August 16, 2022
    Assignees: Children's Medical Center Corporation, Dana-Farber Cancer Institute, Inc.
    Inventors: Wesley Philip Wong, William M. Shih
  • Publication number: 20220160885
    Abstract: The present disclosure provides, in some aspects, nucleic acid nanostructures covalently linked to oligolysine-PEG copolymers.
    Type: Application
    Filed: April 9, 2020
    Publication date: May 26, 2022
    Applicants: President and Fellows of Harvard College, Dana-Farber Cancer Institute, Inc.
    Inventors: William M. Shih, Zhao Zhao, Frances M. Anastassacos
  • Patent number: 11254972
    Abstract: Provided herein, in some embodiments, are methods, compositions and kits for controlling nucleation and assembly of molecular nanostructures, microstructures and macrostructures.
    Type: Grant
    Filed: August 2, 2017
    Date of Patent: February 22, 2022
    Assignees: President and Fellows of Harvard College, Dana-Farber Cancer Institute, Inc.
    Inventors: Dionis Minev, Christopher Wintersinger, William M. Shih
  • Patent number: 10914733
    Abstract: Provided herein are compositions and methods for determining the structure of individual targets using by determining long-range distances within such targets.
    Type: Grant
    Filed: January 5, 2018
    Date of Patent: February 9, 2021
    Assignees: Children's Medical Center Corporation, Dana-Farber Cancer Institute, Inc.
    Inventors: William M. Shih, Wesley Philip Wong
  • Publication number: 20210032683
    Abstract: Provided herein, in some embodiments, are methods and compositions for the production of long single-stranded DNA.
    Type: Application
    Filed: April 11, 2019
    Publication date: February 4, 2021
    Applicant: Dana-Farber Cancer Institute, Inc.
    Inventors: Elisha Krieg, William M. Shih, Dionis Minev, Richard Guerra
  • Patent number: 10876971
    Abstract: Provided herein are, inter alia, barcode probes comprised of transiently or stably fluorescently labeled nucleic acid nanostructures that are fully addressable and able to be read using standard fluorescent microscope and methods of use thereof including methods of use as detectable labels for probes.
    Type: Grant
    Filed: June 14, 2018
    Date of Patent: December 29, 2020
    Assignees: President and Fellows of Harvard College, Dana-Farber Cancer Institute, Inc.
    Inventors: Chenxiang Lin, Chao Li, William M. Shih, Peng Yin, Ralf Jungmann
  • Publication number: 20200308625
    Abstract: The present disclosure provides nucleic acid-based nanoswitch catenanes and methods of use. A nanoswitch catenane may include a single-stranded nucleic acid comprising a first and second terminal domain linked to each other to form a host ring by one of a first, second or third switchable bridges, wherein the first switchable bridge is formed in the presence of a reaction agent through the reaction of two cognate functional groups, each linked to a terminal domain of the single-stranded nucleic acid, wherein the second switchable bridge is formed in the presence of a biomolecule of interest through binding of the bio-molecule of interest to two cognate antibodies, each linked to a terminal domain of the single stranded nucleic acid, and wherein the third switchable bridge is a link between two cognate functional groups that breaks in the presence of a dissociation agent. A nanoswitch catenane may also include a circular nucleic acid guest ring catenated with the host ring.
    Type: Application
    Filed: March 9, 2017
    Publication date: October 1, 2020
    Applicants: Children's Medical Center Corporation, Dana-Farber Cancer Institue, Inc.
    Inventors: Wesley Philip Wong, William M. Shih
  • Publication number: 20200190505
    Abstract: Provided herein, in some embodiments, are methods, compositions and kits for large-scale production of long single-stranded DNA in solution.
    Type: Application
    Filed: September 11, 2017
    Publication date: June 18, 2020
    Applicant: Dana-Farber Cancer Institute, Inc.
    Inventors: Elisha Krieg, William M. Shih
  • Patent number: 10604543
    Abstract: The invention involves the synthesis of nucleic acid structures of controlled size and shape and comprised of a plurality of oligonucleotides. The structures are formed, at least in part, by the self-assembly of single-stranded oligonucleotides. The location of each oligonucleotide in the resultant structure is known. Accordingly, the structures may be modified with specificity.
    Type: Grant
    Filed: July 24, 2013
    Date of Patent: March 31, 2020
    Assignees: President and Fellows of Harvard College, Dana-Farber Cancer Institute, Inc.
    Inventors: Peng Yin, William M. Shih, Yonggang Ke, Luvena L. Ong
  • Publication number: 20190203277
    Abstract: Provided herein, in some embodiments, are methods, compositions and kits for controlling nucleation and assembly of molecular nanostructures, microstructures and macrostructures.
    Type: Application
    Filed: August 2, 2017
    Publication date: July 4, 2019
    Applicants: President and Fellows of Harvard College, Dana-Farber Cancer Institute, Inc.
    Inventors: Dionis Minev, Christopher Wintersinger, William M. Shih
  • Publication number: 20190083522
    Abstract: The present disclosure provides, in some aspects, nucleic acid-based biosynthetic modules for the production of ribonucleic acid (RNA) and other biopolymers.
    Type: Application
    Filed: March 9, 2017
    Publication date: March 21, 2019
    Applicants: President and Fellows of Harvard College, Dana-Farber Cancer Institute, Inc.
    Inventors: William M. Shih, Leo Chou, Rasmus Sorensen, Jaeseung Hahn
  • Publication number: 20190032109
    Abstract: The present disclosure provides, in some aspects, single-molecule timers and clocks, systems and methods for kinetically encoded imaging.
    Type: Application
    Filed: January 26, 2017
    Publication date: January 31, 2019
    Applicant: Dana-Farber Cancer Institute, Inc.
    Inventors: Alexander E. Johnson-Buck, William M. Shih, Bhavik Nathwani
  • Publication number: 20190003973
    Abstract: Provided herein are, inter alia, barcode probes comprised of transiently or stably fluorescently labeled nucleic acid nanostructures that are fully addressable and able to be read using standard fluorescent microscope and methods of use thereof including methods of use as detectable labels for probes.
    Type: Application
    Filed: June 14, 2018
    Publication date: January 3, 2019
    Applicants: President and Fellows of Harvard College, Dana-Farber Cancer Institute, Inc.
    Inventors: Chenxiang Lin, Chao Li, William M. Shih, Peng Yin, Ralf Jungmann
  • Publication number: 20180364225
    Abstract: Provided herein, in some embodiments, are methods of high-throughput screening of small molecules and related compositions and articles of manufacture.
    Type: Application
    Filed: December 7, 2016
    Publication date: December 20, 2018
    Applicants: President and Fellows of Harvard College, Children's Medical Center Corporation, Dana-Farber Cancer Institute, Inc.
    Inventors: Bhavik Nathwani, Darren Yang, Wesley Philip Wong, William M. Shih, Andrew Ward
  • Patent number: D844805
    Type: Grant
    Filed: February 29, 2016
    Date of Patent: April 2, 2019
    Assignees: President and Fellows of Harvard College, Children's Medical Center Corporation, Dana-Farber Cancer Institute, Inc.
    Inventors: Bhavik Nathwani, William M. Shih, Wesley Philip Wong, Darren Yang
  • Patent number: D846755
    Type: Grant
    Filed: December 7, 2016
    Date of Patent: April 23, 2019
    Assignees: President and Fellows of Harvard College, Children's Medical Center Corporation, Dana-Farber Cancer Institute, Inc.
    Inventors: Bhavik Nathwani, William M. Shih, Wesley Philip Wong, Darren Yang